Bosutinib

• Description :

  Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  530.45

• Molecular Formula :

  C26H29Cl2N5O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Abl| MAPK| c-Src

• CAS Number :

  380843-75-4